| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | SP3 RNF168 SIN3A MLLT10 GRHL2 AR STAT3 ZFX ZFY MEN1 ATXN7 MITF KMT2A EP300 | 1.65e-05 | 739 | 99 | 14 | GO:0003682 |
| GeneOntologyMolecularFunction | phosphoprotein binding | 2.92e-04 | 117 | 99 | 5 | GO:0051219 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 5.02e-04 | 566 | 99 | 10 | GO:0001216 | |
| GeneOntologyMolecularFunction | chromatin insulator sequence binding | 5.03e-04 | 7 | 99 | 2 | GO:0043035 | |
| GeneOntologyBiologicalProcess | developmental growth | CDKN1C MYCBP2 DSPP NTRK3 SIN3A STIL GRHL2 GINS1 AR GSK3B STAT3 ZFX ZFY MEN1 VANGL2 BMPR2 UBE3A ZPR1 EP300 | 4.02e-08 | 911 | 97 | 19 | GO:0048589 |
| GeneOntologyBiologicalProcess | growth | CDKN1C MYCBP2 DSPP TRO NTRK3 SIN3A STIL GRHL2 GINS1 AR GSK3B STAT3 ZFX ZFY MEN1 VANGL2 BMPR2 UBE3A ZPR1 EP300 USP47 | 2.23e-07 | 1235 | 97 | 21 | GO:0040007 |
| GeneOntologyBiologicalProcess | embryo development | A2M CDKN1C NUP50 SP3 MBP TRIOBP SIN3A STIL GRHL2 GINS1 AR ZFX ZFY MEN1 VANGL2 BMPR2 ZPR1 KIAA1217 KMT2A PDS5A MYO18B EP300 | 6.54e-07 | 1437 | 97 | 22 | GO:0009790 |
| GeneOntologyBiologicalProcess | chordate embryonic development | CDKN1C NUP50 SP3 SIN3A STIL GRHL2 GINS1 AR MEN1 VANGL2 BMPR2 ZPR1 KIAA1217 PDS5A MYO18B EP300 | 4.73e-06 | 906 | 97 | 16 | GO:0043009 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | CDKN1C NUP50 SP3 SIN3A STIL GRHL2 GINS1 AR MEN1 VANGL2 BMPR2 ZPR1 KIAA1217 PDS5A MYO18B EP300 | 6.50e-06 | 929 | 97 | 16 | GO:0009792 |
| GeneOntologyBiologicalProcess | protein localization to microtubule cytoskeleton | 8.49e-06 | 59 | 97 | 5 | GO:0072698 | |
| GeneOntologyBiologicalProcess | regulation of TORC1 signaling | 8.66e-06 | 102 | 97 | 6 | GO:1903432 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | HMBOX1 SEMG1 CACNB2 ARHGAP24 DOCK11 NTRK3 MBP TAB2 STIL GRHL2 AR GSK3B STAT3 MEN1 VANGL2 AKAP9 CRNN PDGFC MAPRE2 EP300 | 9.09e-06 | 1430 | 97 | 20 | GO:0044093 |
| GeneOntologyBiologicalProcess | regulation of TOR signaling | 9.77e-06 | 158 | 97 | 7 | GO:0032006 | |
| GeneOntologyBiologicalProcess | protein localization to cytoskeleton | 1.17e-05 | 63 | 97 | 5 | GO:0044380 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | ARHGAP24 MBP TRIOBP SIRPA LMOD2 AR GSK3B ZFY CSNK1A1L UBE3A ATXN7 CSNK1A1 KMT2A CGNL1 EP300 | 1.19e-05 | 864 | 97 | 15 | GO:0051129 |
| GeneOntologyBiologicalProcess | TORC1 signaling | 1.27e-05 | 109 | 97 | 6 | GO:0038202 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | MYCBP2 NUMA1 TRIOBP STIL LMOD2 GSK3B VANGL2 AKAP9 ATXN7 CGNL1 MAPRE2 EP300 | 1.74e-05 | 579 | 97 | 12 | GO:0051493 |
| GeneOntologyBiologicalProcess | multicellular organism growth | 2.31e-05 | 249 | 97 | 8 | GO:0035264 | |
| GeneOntologyBiologicalProcess | TOR signaling | 2.36e-05 | 181 | 97 | 7 | GO:0031929 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | 2.56e-05 | 330 | 97 | 9 | GO:0040029 | |
| GeneOntologyBiologicalProcess | regulation of developmental growth | 2.92e-05 | 421 | 97 | 10 | GO:0048638 | |
| GeneOntologyBiologicalProcess | protein localization to microtubule organizing center | 3.33e-05 | 39 | 97 | 4 | GO:1905508 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | MYCBP2 NTRK3 MBP PCDHAC2 TRIOBP SIN3A GRHL2 AR GSK3B VANGL2 BMPR2 CSNK1A1L UBE3A CSNK1A1 IGSF9 EP300 RBFOX2 | 3.81e-05 | 1194 | 97 | 17 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | MYCBP2 NTRK3 MBP PCDHAC2 TRIOBP SIN3A GSK3B VANGL2 BMPR2 UBE3A IGSF9 EP300 RBFOX2 | 4.76e-05 | 748 | 97 | 13 | GO:0048667 |
| GeneOntologyBiologicalProcess | homeostasis of number of cells | 4.93e-05 | 448 | 97 | 10 | GO:0048872 | |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | A2M SEMG1 CCPG1 ARHGAP24 DOCK11 NTRK3 MBP GSK3B STAT3 MEN1 PPP1R2P1 PZP MAPRE2 USP47 | 6.05e-05 | 878 | 97 | 14 | GO:0051336 |
| GeneOntologyBiologicalProcess | multi-organism reproductive process | 6.79e-05 | 290 | 97 | 8 | GO:0044703 | |
| GeneOntologyBiologicalProcess | regulation of growth | MYCBP2 DSPP TRO NTRK3 SIN3A AR GSK3B STAT3 MEN1 BMPR2 ZPR1 EP300 USP47 | 7.01e-05 | 777 | 97 | 13 | GO:0040008 |
| GeneOntologyBiologicalProcess | multi-multicellular organism process | 7.47e-05 | 294 | 97 | 8 | GO:0044706 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | SP3 CCPG1 MLLT10 GRHL2 AR GSK3B STAT3 ZFX ZFY MEN1 BMPR2 UBE3A ATXN7 UBP1 MITF KMT2A EP300 ZNF292 | 7.51e-05 | 1390 | 97 | 18 | GO:0045944 |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | HMBOX1 SEMG1 ARHGAP24 DOCK11 NTRK3 MBP TAB2 STIL GRHL2 GSK3B STAT3 MEN1 VANGL2 PDGFC MAPRE2 | 8.77e-05 | 1028 | 97 | 15 | GO:0043085 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | CDKN1C NUP50 SP3 MBP TRIOBP STIL GRHL2 AR MEN1 VANGL2 BMPR2 PDS5A | 1.29e-04 | 713 | 97 | 12 | GO:0048598 |
| GeneOntologyBiologicalProcess | positive regulation of axon extension | 1.30e-04 | 55 | 97 | 4 | GO:0045773 | |
| GeneOntologyBiologicalProcess | regulation of axon extension | 1.32e-04 | 104 | 97 | 5 | GO:0030516 | |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | SEMG1 MYCBP2 NTRK3 MBP TAB2 STIL GSK3B STAT3 MEN1 VANGL2 BMPR2 CSNK1A1L AKAP9 UBE3A CSNK1A1 TNKS1BP1 PDGFC EP300 | 1.38e-04 | 1458 | 97 | 18 | GO:0051247 |
| GeneOntologyBiologicalProcess | positive regulation of TORC1 signaling | 1.40e-04 | 56 | 97 | 4 | GO:1904263 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex assembly | 1.68e-04 | 173 | 97 | 6 | GO:0031333 | |
| GeneOntologyBiologicalProcess | female pregnancy | 1.75e-04 | 249 | 97 | 7 | GO:0007565 | |
| GeneOntologyBiologicalProcess | regulation of microtubule cytoskeleton organization | 1.84e-04 | 176 | 97 | 6 | GO:0070507 | |
| GeneOntologyBiologicalProcess | regulation of proteolysis | A2M SEMG1 MBP GSK3B STAT3 MEN1 CSNK1A1L UBE3A CSNK1A1 PZP EP300 USP47 | 2.01e-04 | 748 | 97 | 12 | GO:0030162 |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.11e-04 | 115 | 97 | 5 | GO:0090100 | |
| GeneOntologyBiologicalProcess | axon development | MYCBP2 NTRK3 MBP PCDHAC2 SIN3A GSK3B VANGL2 BMPR2 ZPR1 IGSF9 EP300 | 2.14e-04 | 642 | 97 | 11 | GO:0061564 |
| GeneOntologyBiologicalProcess | positive regulation of metalloendopeptidase activity | 2.17e-04 | 5 | 97 | 2 | GO:1904685 | |
| GeneOntologyBiologicalProcess | serotonergic neuron axon guidance | 2.17e-04 | 5 | 97 | 2 | GO:0036515 | |
| GeneOntologyBiologicalProcess | heart development | SGCG NTRK3 ABCC9 TAB2 STIL GRHL2 GSK3B VANGL2 BMPR2 PDS5A MYO18B EP300 | 2.24e-04 | 757 | 97 | 12 | GO:0007507 |
| GeneOntologyBiologicalProcess | definitive hemopoiesis | 2.72e-04 | 27 | 97 | 3 | GO:0060216 | |
| GeneOntologyBiologicalProcess | regulation of extent of cell growth | 2.78e-04 | 122 | 97 | 5 | GO:0061387 | |
| GeneOntologyBiologicalProcess | lung development | 2.81e-04 | 269 | 97 | 7 | GO:0030324 | |
| GeneOntologyBiologicalProcess | respiratory tube development | 3.07e-04 | 273 | 97 | 7 | GO:0030323 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 3.08e-04 | 561 | 97 | 10 | GO:0048568 | |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | CDKN1C NTRK3 TAB2 SIRPA STIL AR GSK3B STAT3 MEN1 VANGL2 BMPR2 AKAP9 ATXN7 PPP1R2P1 TNKS1BP1 PDGFC EP300 | 3.14e-04 | 1421 | 97 | 17 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | CDKN1C NTRK3 TAB2 SIRPA STIL AR GSK3B STAT3 MEN1 VANGL2 BMPR2 AKAP9 ATXN7 PPP1R2P1 TNKS1BP1 PDGFC EP300 | 3.19e-04 | 1423 | 97 | 17 | GO:0051174 |
| GeneOntologyBiologicalProcess | negative regulation of chondrocyte proliferation | 3.24e-04 | 6 | 97 | 2 | GO:1902731 | |
| GeneOntologyBiologicalProcess | axonogenesis | MYCBP2 NTRK3 MBP PCDHAC2 SIN3A GSK3B VANGL2 BMPR2 IGSF9 EP300 | 3.31e-04 | 566 | 97 | 10 | GO:0007409 |
| GeneOntologyBiologicalProcess | negative regulation of intracellular signal transduction | ARHGAP24 SIRPA GSK3B MEN1 SNIP1 CSNK1A1L UBE3A CSNK1A1 DEPDC5 CGNL1 USP47 SEC13 | 3.50e-04 | 795 | 97 | 12 | GO:1902532 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | MYCBP2 NTRK3 MBP PCDHAC2 SIN3A GSK3B VANGL2 BMPR2 UBE3A IGSF9 EP300 RBFOX2 | 3.78e-04 | 802 | 97 | 12 | GO:0048812 |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | 4.02e-04 | 475 | 97 | 9 | GO:0140694 | |
| GeneOntologyBiologicalProcess | negative regulation of TOR signaling | 4.11e-04 | 74 | 97 | 4 | GO:0032007 | |
| GeneOntologyBiologicalProcess | reproductive behavior | 4.11e-04 | 74 | 97 | 4 | GO:0019098 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | ARHGAP24 MYCBP2 DOCK11 NTRK3 NUMA1 TRIOBP STIL LMOD2 GSK3B CSNK1A1L AKAP9 UBAP2L CSNK1A1 CGNL1 EP300 | 4.25e-04 | 1189 | 97 | 15 | GO:0044087 |
| GeneOntologyBiologicalProcess | axon extension | 4.44e-04 | 135 | 97 | 5 | GO:0048675 | |
| GeneOntologyBiologicalProcess | regulation of synaptic assembly at neuromuscular junction | 4.53e-04 | 7 | 97 | 2 | GO:0008582 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | MYCBP2 NTRK3 MBP PCDHAC2 SIN3A GSK3B VANGL2 BMPR2 UBE3A IGSF9 EP300 RBFOX2 | 4.56e-04 | 819 | 97 | 12 | GO:0120039 |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | 4.69e-04 | 293 | 97 | 7 | GO:0032886 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | MYCBP2 NTRK3 MBP PCDHAC2 SIN3A GSK3B VANGL2 BMPR2 UBE3A IGSF9 EP300 RBFOX2 | 4.92e-04 | 826 | 97 | 12 | GO:0048858 |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA poly(A) tail shortening | 4.97e-04 | 33 | 97 | 3 | GO:0000289 | |
| GeneOntologyBiologicalProcess | positive regulation of TOR signaling | 5.02e-04 | 78 | 97 | 4 | GO:0032008 | |
| GeneOntologyBiologicalProcess | positive regulation of proteolysis | 5.08e-04 | 390 | 97 | 8 | GO:0045862 | |
| GeneOntologyBiologicalProcess | regulation of protein modification process | CDKN1C MYCBP2 NTRK3 TAB2 SIRPA STIL GSK3B HMG20A MEN1 VANGL2 BMPR2 AKAP9 UBE3A PPP1R2P1 TNKS1BP1 PDGFC EP300 | 5.34e-04 | 1488 | 97 | 17 | GO:0031399 |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 5.57e-04 | 605 | 97 | 10 | GO:0071407 | |
| GeneOntologyBiologicalProcess | hemopoiesis | CDKN1C SP3 DOCK11 GPATCH4 SIN3A SIRPA GSK3B STAT3 MEN1 MITF TNFRSF13B KMT2A EP300 CNOT4 RBFOX2 | 5.70e-04 | 1223 | 97 | 15 | GO:0030097 |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | 5.73e-04 | 499 | 97 | 9 | GO:0051345 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | CDKN1C NTRK3 TAB2 SIRPA STIL AR GSK3B MEN1 VANGL2 BMPR2 AKAP9 ATXN7 TNKS1BP1 PDGFC EP300 | 5.85e-04 | 1226 | 97 | 15 | GO:0042325 |
| GeneOntologyBiologicalProcess | positive regulation of cellular response to transforming growth factor beta stimulus | 5.92e-04 | 35 | 97 | 3 | GO:1903846 | |
| GeneOntologyBiologicalProcess | positive regulation of transforming growth factor beta receptor signaling pathway | 5.92e-04 | 35 | 97 | 3 | GO:0030511 | |
| GeneOntologyBiologicalProcess | respiratory system development | 5.95e-04 | 305 | 97 | 7 | GO:0060541 | |
| GeneOntologyBiologicalProcess | positive regulation of spindle assembly | 6.02e-04 | 8 | 97 | 2 | GO:1905832 | |
| GeneOntologyBiologicalProcess | skeletal system development | 6.32e-04 | 615 | 97 | 10 | GO:0001501 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | CDKN1C NTRK3 NUMA1 SIN3A GSK3B STAT3 MEN1 BMPR2 UBE3A ZPR1 KMT2A EP300 | 6.34e-04 | 850 | 97 | 12 | GO:0071363 |
| GeneOntologyBiologicalProcess | embryonic skeletal system development | 6.74e-04 | 148 | 97 | 5 | GO:0048706 | |
| GeneOntologyBiologicalProcess | protein localization to centrosome | 7.55e-04 | 38 | 97 | 3 | GO:0071539 | |
| GeneOntologyBiologicalProcess | positive regulation of metallopeptidase activity | 7.71e-04 | 9 | 97 | 2 | GO:1905050 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 7.74e-04 | 416 | 97 | 8 | GO:0030522 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | HMBOX1 CDKN1C SP3 RNF168 TRO ZNF217 SIN3A AR STAT3 HMG20A MEN1 RLIM MITF EP300 RBFOX2 USP47 | 7.85e-04 | 1399 | 97 | 16 | GO:0045892 |
| GeneOntologyBiologicalProcess | tube development | NUP50 SP3 ARHGAP24 DSPP NUMA1 RNF213 STIL GRHL2 AR STAT3 VANGL2 BMPR2 UBP1 MYO18B PDGFC EP300 | 8.03e-04 | 1402 | 97 | 16 | GO:0035295 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | SP3 DSPP TRIOBP ABCC9 STIL GRHL2 AR GSK3B STAT3 MEN1 VANGL2 BMPR2 PDS5A PDGFC EP300 | 8.34e-04 | 1269 | 97 | 15 | GO:0009887 |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | NTRK3 TAB2 STIL AR GSK3B STAT3 VANGL2 BMPR2 AKAP9 TNKS1BP1 PDGFC EP300 | 8.50e-04 | 879 | 97 | 12 | GO:0045937 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | NTRK3 TAB2 STIL AR GSK3B STAT3 VANGL2 BMPR2 AKAP9 TNKS1BP1 PDGFC EP300 | 8.50e-04 | 879 | 97 | 12 | GO:0010562 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | HMBOX1 CDKN1C SP3 RNF168 TRO ZNF217 SIN3A AR STAT3 HMG20A MEN1 RLIM MITF EP300 RBFOX2 USP47 | 8.73e-04 | 1413 | 97 | 16 | GO:1902679 |
| GeneOntologyBiologicalProcess | response to growth factor | CDKN1C NTRK3 NUMA1 SIN3A GSK3B STAT3 MEN1 BMPR2 UBE3A ZPR1 KMT2A EP300 | 8.84e-04 | 883 | 97 | 12 | GO:0070848 |
| GeneOntologyBiologicalProcess | camera-type eye development | 9.02e-04 | 426 | 97 | 8 | GO:0043010 | |
| GeneOntologyBiologicalProcess | T-helper cell differentiation | 9.36e-04 | 92 | 97 | 4 | GO:0042093 | |
| GeneOntologyBiologicalProcess | regulation of neuromuscular junction development | 9.61e-04 | 10 | 97 | 2 | GO:1904396 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell differentiation involved in immune response | 1.01e-03 | 94 | 97 | 4 | GO:0002294 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell differentiation involved in immune response | 1.05e-03 | 95 | 97 | 4 | GO:0002293 | |
| GeneOntologyBiologicalProcess | circulatory system development | ARHGAP24 SGCG NTRK3 RNF213 ABCC9 TAB2 STIL GRHL2 GSK3B STAT3 VANGL2 BMPR2 UBP1 PDS5A MYO18B EP300 | 1.08e-03 | 1442 | 97 | 16 | GO:0072359 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | NTRK3 TAB2 STIL AR GSK3B VANGL2 BMPR2 AKAP9 TNKS1BP1 PDGFC EP300 | 1.09e-03 | 780 | 97 | 11 | GO:0042327 |
| GeneOntologyBiologicalProcess | circadian rhythm | 1.13e-03 | 248 | 97 | 6 | GO:0007623 | |
| GeneOntologyBiologicalProcess | positive regulation of organelle assembly | 1.14e-03 | 97 | 97 | 4 | GO:1902117 | |
| GeneOntologyBiologicalProcess | synaptic assembly at neuromuscular junction | 1.17e-03 | 11 | 97 | 2 | GO:0051124 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell activation involved in immune response | 1.18e-03 | 98 | 97 | 4 | GO:0002287 | |
| GeneOntologyBiologicalProcess | lymphocyte activation involved in immune response | 1.20e-03 | 251 | 97 | 6 | GO:0002285 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 1.28e-03 | 559 | 97 | 9 | GO:0042391 | |
| GeneOntologyBiologicalProcess | response to ketone | 1.28e-03 | 254 | 97 | 6 | GO:1901654 | |
| GeneOntologyCellularComponent | beta-catenin destruction complex | 2.76e-05 | 13 | 98 | 3 | GO:0030877 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | CDKN1C NUP50 SP3 MYCBP2 NTRK3 GRHL2 GSK3B STAT3 ZFX ZFY CHRNG MEN1 VANGL2 BMPR2 KMT2A PDS5A LHX5 WDFY3 PDGFC MN1 EP300 CNOT4 | 1.05e-05 | 1269 | 89 | 22 | MP:0011111 |
| MousePheno | palatal shelves fail to meet at midline | 2.53e-05 | 55 | 89 | 5 | MP:0009888 | |
| MousePheno | abnormal sternum morphology | 3.46e-05 | 255 | 89 | 9 | MP:0000157 | |
| MousePheno | abnormal facial morphology | CDKN1C SP3 RNF168 DSPP MLLT10 GRHL2 GSK3B VANGL2 AKAP9 MITF KMT2A PDS5A LHX5 WDFY3 PDGFC MN1 EP300 | 5.16e-05 | 910 | 89 | 17 | MP:0003743 |
| MousePheno | perinatal lethality | CDKN1C NUP50 SP3 MYCBP2 NTRK3 TNRC6B GSK3B STAT3 ZFX ZFY CHRNG VANGL2 BMPR2 KMT2A PDS5A WDFY3 PDGFC MN1 EP300 | 7.30e-05 | 1130 | 89 | 19 | MP:0002081 |
| MousePheno | coronary artery spasm | 1.20e-04 | 3 | 89 | 2 | MP:0031192 | |
| MousePheno | abnormal palatal shelf morphology | 1.20e-04 | 121 | 89 | 6 | MP:0031460 | |
| MousePheno | abnormal pectoral girdle bone morphology | 1.24e-04 | 301 | 89 | 9 | MP:0004508 | |
| MousePheno | abnormal secondary palate development | 1.37e-04 | 124 | 89 | 6 | MP:0009655 | |
| MousePheno | perinatal lethality, complete penetrance | CDKN1C NUP50 SP3 MYCBP2 NTRK3 GSK3B STAT3 CHRNG VANGL2 KMT2A PDS5A WDFY3 MN1 EP300 | 1.52e-04 | 712 | 89 | 14 | MP:0011089 |
| MousePheno | abnormal palatal shelf fusion at midline | 1.54e-04 | 80 | 89 | 5 | MP:0009887 | |
| MousePheno | split sternum | 1.59e-04 | 17 | 89 | 3 | MP:0004320 | |
| MousePheno | vagina atresia | 1.59e-04 | 17 | 89 | 3 | MP:0001144 | |
| MousePheno | abnormal vertebrae morphology | CDKN1C SP3 RNF168 MLLT10 VANGL2 BMPR2 AKAP9 KIAA1217 RLIM KMT2A PDS5A PDGFC | 1.71e-04 | 546 | 89 | 12 | MP:0000137 |
| MousePheno | abnormal palate development | 1.71e-04 | 129 | 89 | 6 | MP:0009653 | |
| MousePheno | abnormal extraembryonic tissue morphology | CDKN1C SP3 MYCBP2 MLLT10 GRHL2 GINS1 ZFX ZFY VANGL2 BMPR2 UBP1 ZPR1 RLIM WDFY3 EP300 CNOT4 | 1.75e-04 | 908 | 89 | 16 | MP:0002086 |
| MousePheno | decreased prostate gland weight | 2.39e-04 | 4 | 89 | 2 | MP:0004962 | |
| MousePheno | abnormal axial skeleton morphology | HMBOX1 CDKN1C SP3 RNF168 DSPP MLLT10 GRHL2 GSK3B VANGL2 BMPR2 AKAP9 ATXN7 KIAA1217 RLIM MITF KMT2A PDS5A LHX5 GKN1 PDGFC MN1 | 2.57e-04 | 1458 | 89 | 21 | MP:0002114 |
| MousePheno | abnormal craniofacial development | 3.62e-04 | 425 | 89 | 10 | MP:0003935 | |
| Domain | Zfx_Zfy_act | 8.15e-05 | 3 | 98 | 2 | PF04704 | |
| Domain | Transcrp_activ_Zfx/Zfy-dom | 8.15e-05 | 3 | 98 | 2 | IPR006794 | |
| Domain | CP2 | 4.03e-04 | 6 | 98 | 2 | PF04516 | |
| Domain | CP2 | 4.03e-04 | 6 | 98 | 2 | IPR007604 | |
| Domain | A2M_N | 1.19e-03 | 10 | 98 | 2 | PF01835 | |
| Domain | A2M_N | 1.19e-03 | 10 | 98 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.19e-03 | 10 | 98 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.19e-03 | 10 | 98 | 2 | PS00477 | |
| Domain | A2M | 1.19e-03 | 10 | 98 | 2 | PF00207 | |
| Domain | A2M_N_2 | 1.19e-03 | 10 | 98 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.19e-03 | 10 | 98 | 2 | IPR011626 | |
| Domain | A2M_N_2 | 1.19e-03 | 10 | 98 | 2 | PF07703 | |
| Domain | A2M_recep | 1.19e-03 | 10 | 98 | 2 | PF07677 | |
| Domain | A2M_comp | 1.19e-03 | 10 | 98 | 2 | PF07678 | |
| Domain | Macroglobln_a2 | 1.19e-03 | 10 | 98 | 2 | IPR001599 | |
| Domain | - | 2.50e-03 | 449 | 98 | 8 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 2.86e-03 | 459 | 98 | 8 | IPR013083 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 3.95e-03 | 18 | 98 | 2 | IPR008930 | |
| Domain | UBA-like | 4.63e-03 | 64 | 98 | 3 | IPR009060 | |
| Domain | EPHD | 5.88e-03 | 22 | 98 | 2 | PS51805 | |
| Pathway | REACTOME_SUMOYLATION | 2.25e-06 | 169 | 72 | 8 | MM14919 | |
| Pathway | REACTOME_SUMOYLATION | 5.18e-06 | 189 | 72 | 8 | M27214 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 6.80e-06 | 91 | 72 | 6 | M39700 | |
| Pathway | REACTOME_STAT3_NUCLEAR_EVENTS_DOWNSTREAM_OF_ALK_SIGNALING | 2.05e-05 | 11 | 72 | 3 | M42523 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 2.14e-05 | 301 | 72 | 9 | MM15983 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 6.07e-05 | 82 | 72 | 5 | M2 | |
| Pathway | REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE | 9.87e-05 | 18 | 72 | 3 | MM14759 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 1.17e-04 | 19 | 72 | 3 | M48238 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 2.44e-04 | 110 | 72 | 5 | MM15977 | |
| Pathway | REACTOME_SIGNALING_BY_ALK | 4.70e-04 | 30 | 72 | 3 | M42517 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 5.18e-04 | 31 | 72 | 3 | MM15154 | |
| Pathway | WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME | 5.22e-04 | 73 | 72 | 4 | M39401 | |
| Pathway | BIOCARTA_MELANOCYTE_PATHWAY | 5.31e-04 | 7 | 72 | 2 | M22035 | |
| Pathway | BIOCARTA_MELANOCYTE_PATHWAY | 5.31e-04 | 7 | 72 | 2 | MM1555 | |
| Pathway | WP_CIRCADIAN_RHYTHM_GENES | 5.57e-04 | 201 | 72 | 6 | M39605 | |
| Pubmed | CACNB2 ARHGAP24 MYCBP2 DOCK11 NUMA1 TRIOBP TNRC6B SIRPA GSK3B STOX2 CSNK1A1L AKAP9 KIF15 UBE3A UBAP2L CSNK1A1 KIAA1217 WDFY3 | 2.84e-10 | 963 | 100 | 18 | 28671696 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MYCBP2 DOCK11 SEC24A NTRK3 TAB2 STIL STAT3 STOX2 BMPR2 AKAP9 CSNK1A1 KIAA1217 KMT2A TNKS1BP1 CGNL1 SIPA1L2 CNOT4 | 4.11e-10 | 861 | 100 | 17 | 36931259 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CCDC14 RIOK1 SEC24A TNRC6B TAB2 CPD STIL STAT3 MEN1 CSNK1A1 KIAA1217 CGNL1 SIPA1L2 CNOT4 RBFOX2 USP47 | 2.94e-09 | 853 | 100 | 16 | 28718761 |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.07e-08 | 146 | 100 | 8 | 23892456 | |
| Pubmed | Menin is necessary for long term maintenance of meningioma-1 driven leukemia. | 2.31e-08 | 3 | 100 | 3 | 33542482 | |
| Pubmed | SEC24A TNRC6B TAB2 CPD VANGL2 STOX2 CSNK1A1 KIAA1217 SIPA1L2 | 7.37e-08 | 263 | 100 | 9 | 34702444 | |
| Pubmed | MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia. | 9.21e-08 | 4 | 100 | 3 | 26927674 | |
| Pubmed | HMBOX1 SEC24A NUMA1 TNRC6B GPATCH4 ZNF217 SIN3A MLLT10 STAT3 HMG20A UBAP2L ATXN7 RLIM MITF KMT2A PDS5A EP300 SEC13 | 1.25e-07 | 1429 | 100 | 18 | 35140242 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | A2M DOCK11 TNRC6B ZFX ZFY CSNK1A1L UBAP2L CSNK1A1 UBP1 PZP SEC13 | 1.31e-07 | 475 | 100 | 11 | 31040226 |
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 37944068 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | HMBOX1 CACNB2 MYCBP2 MBP TRIOBP TNRC6B RNF213 CPD GRHL2 AR BMPR2 UBAP2L ATXN7 CSNK1A1 KIAA1217 IGSF9 EP300 RBFOX2 | 2.30e-07 | 1489 | 100 | 18 | 28611215 |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.55e-07 | 220 | 100 | 8 | 35785414 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MYCBP2 NUMA1 ZNF217 SIN3A GSK3B ZFX TRAFD1 UBAP2L ATXN7 KMT2A TNKS1BP1 MN1 USP47 | 3.57e-07 | 774 | 100 | 13 | 15302935 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NUP50 RIOK1 NUMA1 TNRC6B GPATCH4 SIN3A STAT3 UBAP2L KIAA1217 KMT2A TNKS1BP1 CGNL1 SIPA1L2 MAPRE2 | 4.79e-07 | 934 | 100 | 14 | 33916271 |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | CDKN1C GSK3B STOX2 TRAFD1 AKAP9 CSNK1A1 KMT2A WDFY3 EP300 SEC13 | 5.04e-07 | 432 | 100 | 10 | 23455922 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 6.55e-07 | 341 | 100 | 9 | 32971831 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | HMBOX1 NUP50 RNF168 NUMA1 GPATCH4 SIN3A ZFX HMG20A MEN1 SNIP1 UBP1 MITF KMT2A PDS5A EP300 RBFOX2 | 8.74e-07 | 1294 | 100 | 16 | 30804502 |
| Pubmed | RIOK1 SEC24A NUMA1 TNRC6B TAB2 CPD STAT3 VANGL2 UBAP2L PDS5A TNKS1BP1 MAPRE2 | 9.47e-07 | 708 | 100 | 12 | 39231216 | |
| Pubmed | HMBOX1 SP3 ZNF217 MLLT10 GRHL2 STAT3 ZFX ZFY ZPR1 KMT2A LHX5 ZNF292 | 9.61e-07 | 709 | 100 | 12 | 22988430 | |
| Pubmed | NUP50 RNF168 NUMA1 RNF213 SIN3A GINS1 STAT3 HMG20A UBE3A CSNK1A1 KMT2A PDS5A METTL16 EP300 | 1.26e-06 | 1014 | 100 | 14 | 32416067 | |
| Pubmed | 1.28e-06 | 8 | 100 | 3 | 27903893 | ||
| Pubmed | Genetic mapping in the region of the mouse X-inactivation center. | 1.28e-06 | 8 | 100 | 3 | 1974879 | |
| Pubmed | High-density molecular map of the central span of the mouse X chromosome. | 1.28e-06 | 8 | 100 | 3 | 1675191 | |
| Pubmed | Conservation of position and exclusive expression of mouse Xist from the inactive X chromosome. | 1.28e-06 | 8 | 100 | 3 | 2034279 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | SIN3A MLLT10 AR STAT3 ZFY HMG20A UBP1 RLIM MITF LHX5 EP300 RBFOX2 ZNF292 | 1.44e-06 | 877 | 100 | 13 | 20211142 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | RIOK1 SEC24A TAB2 GSK3B TRAFD1 UBAP2L CSNK1A1 UBP1 KIAA1217 MITF TNKS1BP1 CNOT4 USP47 SEC13 | 1.66e-06 | 1038 | 100 | 14 | 26673895 |
| Pubmed | 1.91e-06 | 9 | 100 | 3 | 15199122 | ||
| Pubmed | 1.91e-06 | 9 | 100 | 3 | 7590750 | ||
| Pubmed | Cloning and characterization of a new human Xq13 gene, encoding a putative helicase. | 1.91e-06 | 9 | 100 | 3 | 7874112 | |
| Pubmed | 1.91e-06 | 9 | 100 | 3 | 9601641 | ||
| Pubmed | 2.73e-06 | 10 | 100 | 3 | 2055107 | ||
| Pubmed | 2.79e-06 | 76 | 100 | 5 | 27542412 | ||
| Pubmed | Characterization of a murine gene expressed from the inactive X chromosome. | 3.74e-06 | 11 | 100 | 3 | 2034278 | |
| Pubmed | 3.74e-06 | 11 | 100 | 3 | 21709260 | ||
| Pubmed | SEMG1 TNRC6B RNF213 GPATCH4 SIN3A HMG20A VANGL2 SNIP1 TRAFD1 ATXN7 CRNN WDFY3 SIPA1L2 EP300 | 3.84e-06 | 1116 | 100 | 14 | 31753913 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | MYCBP2 MBP TRIOBP SIN3A HMG20A UBE3A UBAP2L UBP1 IGSF9 RBFOX2 | 5.12e-06 | 560 | 100 | 10 | 21653829 |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | A2M CDKN1C NUP50 GSK3B TRAFD1 AKAP9 UBAP2L TNKS1BP1 SIPA1L2 EP300 SEC13 | 5.31e-06 | 695 | 100 | 11 | 23602568 |
| Pubmed | 6.43e-06 | 90 | 100 | 5 | 19515997 | ||
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 16469706 | ||
| Pubmed | Rps4 maps near the inactivation center on the mouse X chromosome. | 6.46e-06 | 13 | 100 | 3 | 1740345 | |
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 2721933 | ||
| Pubmed | XIST and the mapping of the X chromosome inactivation centre. | 6.46e-06 | 13 | 100 | 3 | 1772416 | |
| Pubmed | 6.46e-06 | 13 | 100 | 3 | 7805729 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 25846563 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 28574599 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 23354688 | ||
| Pubmed | Targeting the MLL complex in castration-resistant prostate cancer. | 8.18e-06 | 2 | 100 | 2 | 25822367 | |
| Pubmed | Zfa is an expressed retroposon derived from an alternative transcript of the Zfx gene. | 8.18e-06 | 2 | 100 | 2 | 1691708 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 8188262 | ||
| Pubmed | Tissue-specific distribution of mouse casein kinase I alpha mRNA. | 8.18e-06 | 2 | 100 | 2 | 9522121 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 34885717 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 1692292 | ||
| Pubmed | CSNK1A1/CK1α suppresses autoimmunity by restraining the CGAS-STING1 signaling. | 8.18e-06 | 2 | 100 | 2 | 37723657 | |
| Pubmed | Mapping the human ZFX locus to Xp21.3 by in situ hybridization. | 8.18e-06 | 2 | 100 | 2 | 2497060 | |
| Pubmed | Casein Kinase 1α Regulates Testosterone Synthesis and Testis Development in Adult Mice. | 8.18e-06 | 2 | 100 | 2 | 36929849 | |
| Pubmed | Recruitment of MLL by HMG-domain protein iBRAF promotes neural differentiation. | 8.18e-06 | 2 | 100 | 2 | 16227968 | |
| Pubmed | Comparison of ZFY and ZFX gene structure and analysis of alternative 3' untranslated regions of ZFY. | 8.18e-06 | 2 | 100 | 2 | 2041734 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 8318216 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 17671686 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 20961854 | ||
| Pubmed | [Expression of Zfx in mouse testicular spermatogenic cells]. | 8.18e-06 | 2 | 100 | 2 | 38602753 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 12127405 | ||
| Pubmed | Inhibition of MITF transcriptional activity independent of targeting p300/CBP coactivators. | 8.18e-06 | 2 | 100 | 2 | 17250547 | |
| Pubmed | Interaction of MLL amino terminal sequences with menin is required for transformation. | 8.18e-06 | 2 | 100 | 2 | 17671196 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 12716983 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 35695793 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 23744037 | ||
| Pubmed | Intron/exon structure confirms that mouse Zfy1 and Zfy2 are members of the ZFY gene family. | 8.18e-06 | 2 | 100 | 2 | 9126493 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 15178691 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 35008530 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 12093801 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 30499465 | ||
| Pubmed | Exploring the role of casein kinase 1α splice variants across cancer cell lines. | 8.18e-06 | 2 | 100 | 2 | 38852281 | |
| Pubmed | Evolution of the Zfx and Zfy genes: rates and interdependence between the genes. | 8.18e-06 | 2 | 100 | 2 | 8487630 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 25327559 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 22936661 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 23690993 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 21493871 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 14737107 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 11811950 | ||
| Pubmed | Knockdown of Csnk1a1 results in preimplantation developmental arrest in mice. | 8.18e-06 | 2 | 100 | 2 | 36542875 | |
| Pubmed | Zfx mutation results in small animal size and reduced germ cell number in male and female mice. | 8.18e-06 | 2 | 100 | 2 | 9187153 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 34078089 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 2265557 | ||
| Pubmed | STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-alpha3. | 8.18e-06 | 2 | 100 | 2 | 15919823 | |
| Pubmed | Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy. | 8.18e-06 | 2 | 100 | 2 | 18806775 | |
| Pubmed | Kmt2a cooperates with menin to suppress tumorigenesis in mouse pancreatic islets. | 8.18e-06 | 2 | 100 | 2 | 27801610 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 20231377 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 19364825 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 11322786 | ||
| Pubmed | Drosophila glucome screening identifies Ck1alpha as a regulator of mammalian glucose metabolism. | 8.18e-06 | 2 | 100 | 2 | 25994086 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 2105457 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 38003662 | ||
| Pubmed | SLCO1B3 promotes colorectal cancer tumorigenesis and metastasis through STAT3. | 8.18e-06 | 2 | 100 | 2 | 34526411 | |
| Pubmed | MITF Expression Predicts Therapeutic Vulnerability to p300 Inhibition in Human Melanoma. | 8.18e-06 | 2 | 100 | 2 | 30910803 | |
| Pubmed | STAT3 sensitizes insulin signaling by negatively regulating glycogen synthase kinase-3 beta. | 8.18e-06 | 2 | 100 | 2 | 18268048 | |
| Pubmed | Transcription factor Zfx controls BCR-induced proliferation and survival of B lymphocytes. | 8.18e-06 | 2 | 100 | 2 | 19329779 | |
| Pubmed | Tumorigenicity of Ewing sarcoma is critically dependent on the trithorax proteins MLL1 and menin. | 8.18e-06 | 2 | 100 | 2 | 27888797 | |
| Pubmed | Chromosomal localization of ZFX--a human gene that escapes X inactivation--and its murine homologs. | 8.18e-06 | 2 | 100 | 2 | 1970799 | |
| Pubmed | Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. | 8.18e-06 | 2 | 100 | 2 | 15640349 | |
| Interaction | SEC23B interactions | 1.42e-07 | 222 | 99 | 10 | int:SEC23B | |
| Interaction | SUMO1 interactions | SP3 RNF168 NUMA1 AR SNIP1 AKAP9 UBE3A ATXN7 MITF PDGFC EP300 | 1.68e-07 | 287 | 99 | 11 | int:SUMO1 |
| Interaction | AR interactions | MYCBP2 NUMA1 RNF213 TAB2 ZNF217 SIN3A GRHL2 AR GSK3B STAT3 KIF15 UBE3A UBAP2L CSNK1A1 KIAA1217 KMT2A PDS5A EP300 SEC13 | 3.04e-07 | 992 | 99 | 19 | int:AR |
| Interaction | KDM1A interactions | CCDC14 RIOK1 RNF168 MYCBP2 TNRC6B ZNF217 SIN3A AR GSK3B STAT3 HMG20A AKAP9 KIF15 CSNK1A1 KIAA1217 PDS5A TNKS1BP1 EP300 | 6.66e-07 | 941 | 99 | 18 | int:KDM1A |
| Interaction | YWHAZ interactions | MYCBP2 DOCK11 HS6ST2 SEC24A MBP TAB2 AR GSK3B RIN1 STOX2 AKAP9 KIF15 UBE3A CSNK1A1 KMT2A DEPDC5 CGNL1 WDFY3 SIPA1L2 EP300 USP47 | 1.36e-06 | 1319 | 99 | 21 | int:YWHAZ |
| Interaction | PCM1 interactions | CCDC14 RNF168 MYCBP2 TRO TRIOBP STIL AR GSK3B AKAP9 KIF15 CSNK1A1 KIAA1217 | 1.46e-06 | 434 | 99 | 12 | int:PCM1 |
| Interaction | SYNE3 interactions | CCDC14 CCPG1 SEC24A TNRC6B TAB2 CPD STIL GSK3B CSNK1A1 KIAA1217 CGNL1 SIPA1L2 | 1.84e-06 | 444 | 99 | 12 | int:SYNE3 |
| Interaction | GTF2I interactions | RIOK1 ARHGAP24 NUMA1 TAB2 ZNF217 SIN3A AR STAT3 MEN1 RLIM EP300 | 2.22e-06 | 373 | 99 | 11 | int:GTF2I |
| Interaction | TLE3 interactions | SEC24A ZNF217 MLLT10 AR GSK3B MEN1 KMT2A TNKS1BP1 EP300 CNOT4 USP47 | 2.39e-06 | 376 | 99 | 11 | int:TLE3 |
| Interaction | STAT2 interactions | 2.91e-06 | 81 | 99 | 6 | int:STAT2 | |
| Interaction | HDAC1 interactions | NUP50 SP3 RIOK1 MYCBP2 TNRC6B TAB2 ZNF217 SIN3A AR STAT3 HMG20A MEN1 AKAP9 KIF15 KMT2A TNKS1BP1 EP300 USP47 | 6.68e-06 | 1108 | 99 | 18 | int:HDAC1 |
| Interaction | PIAS3 interactions | 7.36e-06 | 95 | 99 | 6 | int:PIAS3 | |
| Interaction | CTNNB1 interactions | HMBOX1 ARHGAP24 NTRK3 NUMA1 MLLT10 AR GSK3B MEN1 UBE3A CSNK1A1 KIAA1217 MITF KMT2A CGNL1 SIPA1L2 EP300 SEC13 | 7.77e-06 | 1009 | 99 | 17 | int:CTNNB1 |
| Interaction | RNF43 interactions | SEC24A TNRC6B TAB2 CPD GSK3B VANGL2 STOX2 CSNK1A1 KIAA1217 SIPA1L2 SEC13 | 8.04e-06 | 427 | 99 | 11 | int:RNF43 |
| Interaction | RAI1 interactions | 9.90e-06 | 100 | 99 | 6 | int:RAI1 | |
| Interaction | FMR1 interactions | HMBOX1 CACNB2 ARHGAP24 MYCBP2 NUMA1 TNRC6B GSK3B VANGL2 AKAP9 UBAP2L KIAA1217 WDFY3 | 1.25e-05 | 536 | 99 | 12 | int:FMR1 |
| Interaction | EEA1 interactions | 1.53e-05 | 162 | 99 | 7 | int:EEA1 | |
| Interaction | CNOT4 interactions | 1.69e-05 | 65 | 99 | 5 | int:CNOT4 | |
| Interaction | RPRD1B interactions | 1.96e-05 | 233 | 99 | 8 | int:RPRD1B | |
| Interaction | TNPO1 interactions | 2.00e-05 | 306 | 99 | 9 | int:TNPO1 | |
| Interaction | HDAC2 interactions | SP3 MYCBP2 ZNF217 SIN3A AR STAT3 HMG20A MEN1 CSNK1A1 RLIM KMT2A TNKS1BP1 EP300 CNOT4 SEC13 | 2.03e-05 | 865 | 99 | 15 | int:HDAC2 |
| Interaction | KHSRP interactions | 2.10e-05 | 308 | 99 | 9 | int:KHSRP | |
| Interaction | YWHAH interactions | MYCBP2 DOCK11 SEC24A TAB2 STIL RIN1 STOX2 AKAP9 UBE3A CSNK1A1 KIAA1217 MITF KMT2A TNKS1BP1 CGNL1 SIPA1L2 CNOT4 | 2.43e-05 | 1102 | 99 | 17 | int:YWHAH |
| Interaction | ZFY interactions | 2.45e-05 | 12 | 99 | 3 | int:ZFY | |
| Interaction | PIAS2 interactions | 3.01e-05 | 180 | 99 | 7 | int:PIAS2 | |
| Interaction | H2BC3 interactions | RIOK1 ARHGAP24 RNF168 NUMA1 SIN3A HMG20A MEN1 KMT2A PDS5A EP300 | 3.12e-05 | 406 | 99 | 10 | int:H2BC3 |
| Interaction | BICD1 interactions | 3.25e-05 | 250 | 99 | 8 | int:BICD1 | |
| Interaction | TBP interactions | 3.53e-05 | 253 | 99 | 8 | int:TBP | |
| Interaction | STIL interactions | 4.25e-05 | 190 | 99 | 7 | int:STIL | |
| Interaction | RBM26 interactions | 4.40e-05 | 130 | 99 | 6 | int:RBM26 | |
| Interaction | ATOH1 interactions | 4.64e-05 | 80 | 99 | 5 | int:ATOH1 | |
| Interaction | PML interactions | NUP50 SP3 NUMA1 TNRC6B RNF213 SIN3A STAT3 UBE3A UBAP2L ATXN7 MITF KMT2A PDS5A TNKS1BP1 EP300 | 4.86e-05 | 933 | 99 | 15 | int:PML |
| Interaction | MYB interactions | 5.00e-05 | 133 | 99 | 6 | int:MYB | |
| Interaction | E2F1 interactions | 5.88e-05 | 200 | 99 | 7 | int:E2F1 | |
| Interaction | SMARCC2 interactions | 6.07e-05 | 353 | 99 | 9 | int:SMARCC2 | |
| Interaction | CDX2 interactions | 6.57e-05 | 86 | 99 | 5 | int:CDX2 | |
| Interaction | NIN interactions | CCDC14 TNRC6B STIL GSK3B MEN1 CSNK1A1 KIAA1217 CGNL1 SIPA1L2 | 6.91e-05 | 359 | 99 | 9 | int:NIN |
| Interaction | TNRC6A interactions | 7.21e-05 | 280 | 99 | 8 | int:TNRC6A | |
| Interaction | PZP interactions | 7.44e-05 | 17 | 99 | 3 | int:PZP | |
| Interaction | GSN interactions | 8.48e-05 | 212 | 99 | 7 | int:GSN | |
| Interaction | MCM6 interactions | 8.57e-05 | 287 | 99 | 8 | int:MCM6 | |
| Interaction | KCNA3 interactions | RIOK1 SEC24A NUMA1 TNRC6B RNF213 TAB2 CPD STAT3 VANGL2 UBAP2L KMT2A PDS5A TNKS1BP1 MAPRE2 | 8.92e-05 | 871 | 99 | 14 | int:KCNA3 |
| Interaction | DVL2 interactions | DSPP NUMA1 STIL GSK3B VANGL2 SNIP1 CSNK1A1L AKAP9 CSNK1A1 CGNL1 EP300 | 9.12e-05 | 557 | 99 | 11 | int:DVL2 |
| Interaction | GTSE1 interactions | 9.25e-05 | 215 | 99 | 7 | int:GTSE1 | |
| Interaction | RERE interactions | 9.54e-05 | 93 | 99 | 5 | int:RERE | |
| Interaction | SIN3A interactions | 1.07e-04 | 380 | 99 | 9 | int:SIN3A | |
| Interaction | GSE1 interactions | 1.13e-04 | 154 | 99 | 6 | int:GSE1 | |
| Interaction | YWHAG interactions | MYCBP2 DOCK11 SEC24A TAB2 STAT3 SNIP1 RIN1 STOX2 AKAP9 KIF15 UBE3A CSNK1A1 MITF KMT2A CGNL1 SIPA1L2 CNOT4 | 1.14e-04 | 1248 | 99 | 17 | int:YWHAG |
| Interaction | SENP3 interactions | 1.19e-04 | 301 | 99 | 8 | int:SENP3 | |
| Interaction | SRSF9 interactions | 1.19e-04 | 224 | 99 | 7 | int:SRSF9 | |
| Interaction | SQSTM1 interactions | CCPG1 RNF168 NTRK3 MBP TNRC6B TAB2 AR GSK3B MEN1 VANGL2 UBAP2L CSNK1A1 MITF TNKS1BP1 WDFY3 MAPRE2 CNOT4 | 1.24e-04 | 1257 | 99 | 17 | int:SQSTM1 |
| Interaction | H3C1 interactions | CDKN1C NUP50 RIOK1 NUMA1 GPATCH4 SIN3A GSK3B MEN1 RLIM KMT2A PDS5A MAPRE2 EP300 ZNF292 | 1.27e-04 | 901 | 99 | 14 | int:H3C1 |
| Interaction | NANOG interactions | SIN3A GRHL2 MEN1 AKAP9 CSNK1A1 KIAA1217 SIPA1L2 EP300 RBFOX2 SEC13 | 1.28e-04 | 481 | 99 | 10 | int:NANOG |
| Interaction | NAA15 interactions | 1.30e-04 | 158 | 99 | 6 | int:NAA15 | |
| Interaction | FOXC1 interactions | 1.33e-04 | 228 | 99 | 7 | int:FOXC1 | |
| Interaction | SASS6 interactions | 1.34e-04 | 159 | 99 | 6 | int:SASS6 | |
| Interaction | KDM3B interactions | 1.34e-04 | 100 | 99 | 5 | int:KDM3B | |
| Interaction | EWSR1 interactions | RNF168 MYCBP2 SEC24A NUMA1 ZNF217 GSK3B MEN1 UBAP2L UBP1 RLIM KMT2A EP300 ZNF292 SEC13 | 1.35e-04 | 906 | 99 | 14 | int:EWSR1 |
| Interaction | NFKB1 interactions | 1.36e-04 | 307 | 99 | 8 | int:NFKB1 | |
| Interaction | SLC22A13 interactions | 1.42e-04 | 4 | 99 | 2 | int:SLC22A13 | |
| Interaction | FHL2 interactions | 1.45e-04 | 396 | 99 | 9 | int:FHL2 | |
| Interaction | SFN interactions | MYCBP2 DOCK11 NTRK3 TAB2 STAT3 STOX2 AKAP9 KMT2A CGNL1 SIPA1L2 MAPRE2 USP47 | 1.47e-04 | 692 | 99 | 12 | int:SFN |
| Interaction | H3C3 interactions | RIOK1 RNF168 NUMA1 GPATCH4 SIN3A HMG20A RLIM KMT2A PDS5A ZNF292 | 1.61e-04 | 495 | 99 | 10 | int:H3C3 |
| Interaction | LRRC49 interactions | 1.62e-04 | 104 | 99 | 5 | int:LRRC49 | |
| Interaction | SEC31A interactions | 1.65e-04 | 236 | 99 | 7 | int:SEC31A | |
| Interaction | LDB2 interactions | 1.65e-04 | 56 | 99 | 4 | int:LDB2 | |
| Interaction | SMG7 interactions | 1.77e-04 | 319 | 99 | 8 | int:SMG7 | |
| Interaction | UNK interactions | SEC24A TNRC6B SIN3A GSK3B MFSD14B UBAP2L RLIM TNKS1BP1 RBFOX2 | 1.82e-04 | 408 | 99 | 9 | int:UNK |
| Interaction | SMC3 interactions | 1.82e-04 | 408 | 99 | 9 | int:SMC3 | |
| Interaction | WDR59 interactions | 2.02e-04 | 109 | 99 | 5 | int:WDR59 | |
| Interaction | TRIP10 interactions | 2.02e-04 | 109 | 99 | 5 | int:TRIP10 | |
| Interaction | HMMR interactions | 2.02e-04 | 109 | 99 | 5 | int:HMMR | |
| Interaction | PFN1 interactions | ARHGAP24 SIRPA MLLT10 AR GSK3B AKAP9 KIF15 KIAA1217 TNKS1BP1 SIPA1L2 | 2.02e-04 | 509 | 99 | 10 | int:PFN1 |
| Interaction | PARP1 interactions | ARHGAP24 RNF168 MYCBP2 NUMA1 GPATCH4 SIN3A AR GSK3B HMG20A TRAFD1 CSNK1A1 UBP1 RLIM PDS5A CGNL1 EP300 ZNF292 | 2.15e-04 | 1316 | 99 | 17 | int:PARP1 |
| Interaction | KLK3 interactions | 2.16e-04 | 60 | 99 | 4 | int:KLK3 | |
| Interaction | PPP2R5D interactions | 2.19e-04 | 174 | 99 | 6 | int:PPP2R5D | |
| Interaction | HNRNPM interactions | RIOK1 ARHGAP24 RNF168 AR GSK3B STAT3 MEN1 SNIP1 AKAP9 CSNK1A1 RLIM EP300 | 2.20e-04 | 723 | 99 | 12 | int:HNRNPM |
| Interaction | AFDN interactions | 2.37e-04 | 333 | 99 | 8 | int:AFDN | |
| Interaction | PXN interactions | 2.42e-04 | 334 | 99 | 8 | int:PXN | |
| Interaction | GRHL2 interactions | 2.44e-04 | 25 | 99 | 3 | int:GRHL2 | |
| Interaction | SEC23A interactions | 2.65e-04 | 255 | 99 | 7 | int:SEC23A | |
| Interaction | FOXP3 interactions | 2.77e-04 | 432 | 99 | 9 | int:FOXP3 | |
| Interaction | DEAF1 interactions | 2.78e-04 | 64 | 99 | 4 | int:DEAF1 | |
| Interaction | PAX5 interactions | 2.78e-04 | 64 | 99 | 4 | int:PAX5 | |
| Interaction | SMAD4 interactions | 2.79e-04 | 530 | 99 | 10 | int:SMAD4 | |
| Interaction | PHF21A interactions | 2.90e-04 | 343 | 99 | 8 | int:PHF21A | |
| Interaction | H2BC4 interactions | 2.91e-04 | 259 | 99 | 7 | int:H2BC4 | |
| Interaction | NXF2 interactions | 2.95e-04 | 65 | 99 | 4 | int:NXF2 | |
| Interaction | NAA40 interactions | NUP50 RIOK1 NUMA1 TNRC6B GPATCH4 SIN3A STAT3 UBAP2L KIAA1217 KMT2A TNKS1BP1 CGNL1 SIPA1L2 MAPRE2 | 2.97e-04 | 978 | 99 | 14 | int:NAA40 |
| Interaction | NOL11 interactions | 3.03e-04 | 119 | 99 | 5 | int:NOL11 | |
| Interaction | XAB2 interactions | 3.14e-04 | 186 | 99 | 6 | int:XAB2 | |
| Interaction | LAMP1 interactions | ARHGAP24 SEC24A NTRK3 MBP TRIOBP CPD VANGL2 CSNK1A1 TNKS1BP1 DEPDC5 SEC13 | 3.21e-04 | 644 | 99 | 11 | int:LAMP1 |
| Interaction | NPRL2 interactions | 3.27e-04 | 121 | 99 | 5 | int:NPRL2 | |
| Interaction | PSMD1 interactions | 3.28e-04 | 442 | 99 | 9 | int:PSMD1 | |
| Interaction | SPI1 interactions | 3.31e-04 | 67 | 99 | 4 | int:SPI1 | |
| Interaction | SCRIB interactions | 3.42e-04 | 266 | 99 | 7 | int:SCRIB | |
| Interaction | H2BC9 interactions | 3.50e-04 | 446 | 99 | 9 | int:H2BC9 | |
| Interaction | UBC interactions | 3.50e-04 | 446 | 99 | 9 | int:UBC | |
| Interaction | DAXX interactions | 3.51e-04 | 353 | 99 | 8 | int:DAXX | |
| Interaction | HNF1B interactions | 3.52e-04 | 190 | 99 | 6 | int:HNF1B | |
| Cytoband | 10p12 | 9.79e-05 | 7 | 100 | 2 | 10p12 | |
| Cytoband | 1q22-q23 | 3.61e-04 | 13 | 100 | 2 | 1q22-q23 | |
| Cytoband | 22q13.1 | 8.70e-04 | 85 | 100 | 3 | 22q13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q12 | 1.79e-03 | 235 | 100 | 4 | chr22q12 | |
| Cytoband | 22q12.1 | 2.23e-03 | 32 | 100 | 2 | 22q12.1 | |
| Cytoband | 20p11.21 | 2.37e-03 | 33 | 100 | 2 | 20p11.21 | |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 2.48e-04 | 7 | 63 | 2 | 1350 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 4.23e-04 | 9 | 63 | 2 | 1234 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SP3 MYCBP2 SEC24A TAB2 STIL GINS1 GSK3B AKAP9 UBE3A CSNK1A1 MITF PDS5A WDFY3 MN1 CNOT4 RBFOX2 ZNF292 | 2.45e-08 | 856 | 100 | 17 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MYCBP2 SEC24A TAB2 STIL GINS1 GSK3B AKAP9 UBE3A PDS5A CNOT4 RBFOX2 ZNF292 | 2.21e-07 | 466 | 100 | 12 | M13522 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SP3 MYCBP2 DOCK11 MBP NUMA1 TNRC6B RNF213 TAB2 ZNF217 SIN3A STAT3 AKAP9 UBE3A ATXN7 KMT2A PDS5A MAPRE2 EP300 USP47 ZNF292 | 7.58e-07 | 1492 | 100 | 20 | M40023 |
| Coexpression | GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_UP | 9.82e-07 | 199 | 100 | 8 | M7845 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 4.17e-06 | 323 | 100 | 9 | M9150 | |
| Coexpression | GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_UP | 1.19e-05 | 200 | 100 | 7 | M9041 | |
| Coexpression | MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP | 2.11e-05 | 87 | 100 | 5 | M945 | |
| Coexpression | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23 | 4.99e-05 | 19 | 100 | 3 | M13194 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | NUP50 RIOK1 GSK3B ZFX UBAP2L ATXN7 CSNK1A1 PDS5A METTL16 EP300 ZNF292 | 5.78e-05 | 680 | 100 | 11 | M41089 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 6.74e-05 | 180 | 100 | 6 | M8239 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | HMBOX1 CDKN1C NUP50 SEC24A MBP GSK3B ZFX SNIP1 AKAP9 WDFY3 EP300 CNOT4 | 7.00e-05 | 822 | 100 | 12 | M6782 |
| Coexpression | GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_UP | 9.62e-05 | 192 | 100 | 6 | M7558 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | TRIOBP TNRC6B VANGL2 CSNK1A1L UBAP2L CSNK1A1 TNKS1BP1 SIPA1L2 RBFOX2 | 9.97e-05 | 484 | 100 | 9 | MM999 |
| Coexpression | GSE22886_NAIVE_VS_MEMORY_TCELL_UP | 1.02e-04 | 194 | 100 | 6 | M4416 | |
| Coexpression | GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP | 1.14e-04 | 198 | 100 | 6 | M3200 | |
| Coexpression | GSE31082_DN_VS_DP_THYMOCYTE_DN | 1.20e-04 | 200 | 100 | 6 | M5055 | |
| Coexpression | GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN | 1.20e-04 | 200 | 100 | 6 | M7868 | |
| Coexpression | GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP | 1.20e-04 | 200 | 100 | 6 | M3461 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP | 1.20e-04 | 200 | 100 | 6 | M8497 | |
| Coexpression | GSE22886_IGA_VS_IGM_MEMORY_BCELL_DN | 1.20e-04 | 200 | 100 | 6 | M4439 | |
| Coexpression | KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_UP | 1.20e-04 | 200 | 100 | 6 | M3012 | |
| Coexpression | GABRIELY_MIR21_TARGETS | 1.23e-04 | 289 | 100 | 7 | M2196 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_UP | 1.33e-04 | 128 | 100 | 5 | M8945 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 1.49e-04 | 208 | 100 | 6 | MM581 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | HMBOX1 SP3 SIN3A MLLT10 GRHL2 VANGL2 UBAP2L RLIM CGNL1 WDFY3 ZNF292 | 1.85e-04 | 776 | 100 | 11 | M1107 |
| Coexpression | TABULA_MURIS_SENIS_BROWN_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | CDKN1C AR ZFX ZFY HMG20A CSNK1A1L AKAP9 CSNK1A1 UBP1 PPP1R2P1 WDFY3 MN1 SEC13 | 1.87e-04 | 1055 | 100 | 13 | MM3677 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN | HMBOX1 SP3 SIN3A MLLT10 GRHL2 VANGL2 UBAP2L RLIM CGNL1 WDFY3 ZNF292 | 2.25e-04 | 794 | 100 | 11 | MM982 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | SP3 DOCK11 CPD AR GSK3B UBE3A KIAA1217 RLIM DEPDC5 WDFY3 CNOT4 RBFOX2 | 3.58e-07 | 413 | 96 | 12 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | SP3 DOCK11 HS6ST2 RNF213 CPD GSK3B ZFX ALKBH8 UBE3A UBAP2L CSNK1A1 KIAA1217 RLIM DEPDC5 WDFY3 CNOT4 | 6.00e-07 | 804 | 96 | 16 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | SP3 DOCK11 NTRK3 ABCC9 CPD AR GSK3B STAT3 UBE3A KIAA1217 RLIM DEPDC5 WDFY3 CNOT4 RBFOX2 | 2.88e-06 | 799 | 96 | 15 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | SP3 DOCK11 CPD GSK3B STAT3 ZFX VANGL2 ALKBH8 UBE3A UBAP2L RLIM DEPDC5 WDFY3 CNOT4 RBFOX2 | 3.67e-06 | 815 | 96 | 15 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.62e-06 | 151 | 96 | 7 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | SP3 DOCK11 ABCC9 CPD AR GSK3B STAT3 UBE3A KIAA1217 RLIM DEPDC5 WDFY3 CNOT4 RBFOX2 | 1.23e-05 | 790 | 96 | 14 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | SP3 DOCK11 CPD AR GSK3B STAT3 ALKBH8 UBE3A KIAA1217 RLIM DEPDC5 WDFY3 CNOT4 RBFOX2 | 1.43e-05 | 801 | 96 | 14 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 1.53e-05 | 406 | 96 | 10 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | SP3 DOCK11 HS6ST2 RNF213 CPD SIN3A GSK3B STOX2 UBAP2L KIAA1217 RLIM DEPDC5 WDFY3 CNOT4 | 1.54e-05 | 806 | 96 | 14 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | SP3 CACNB2 HS6ST2 RNF213 CPD AR GSK3B STAT3 UBE3A UBAP2L RLIM WDFY3 CNOT4 | 4.26e-05 | 770 | 96 | 13 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.09e-05 | 375 | 96 | 9 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | SP3 CACNB2 DOCK11 HS6ST2 RNF213 CPD GSK3B STAT3 UBE3A RLIM DEPDC5 WDFY3 CNOT4 | 5.91e-05 | 795 | 96 | 13 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 6.18e-05 | 150 | 96 | 6 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.32e-05 | 225 | 96 | 7 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | HMBOX1 RNF168 TRO SEC24A MBP GINS1 ZFX DEPDC5 WDFY3 EP300 ZNF292 | 7.79e-05 | 595 | 96 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.88e-05 | 397 | 96 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.40e-05 | 230 | 96 | 7 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 9.00e-05 | 404 | 96 | 9 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 9.46e-05 | 162 | 96 | 6 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.09e-04 | 323 | 96 | 8 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.36e-04 | 173 | 96 | 6 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_500 | 1.37e-04 | 109 | 96 | 5 | gudmap_developingGonad_e16.5_ovary_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500 | 1.44e-04 | 175 | 96 | 6 | gudmap_developingGonad_e14.5_ epididymis_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | SP3 DOCK11 HS6ST2 RNF213 CPD GSK3B ZFX UBE3A UBAP2L RLIM DEPDC5 CNOT4 | 1.95e-04 | 776 | 96 | 12 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | SP3 CACNB2 HS6ST2 RNF213 CPD AR GSK3B STAT3 UBE3A RLIM WDFY3 CNOT4 | 2.00e-04 | 778 | 96 | 12 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#2_top-relative-expression-ranked_500 | 2.15e-04 | 65 | 96 | 4 | gudmap_developingGonad_P2_ovary_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#3_top-relative-expression-ranked_500 | 2.32e-04 | 122 | 96 | 5 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.53e-04 | 275 | 96 | 7 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 2.75e-04 | 469 | 96 | 9 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | MYCBP2 SGCG CPD GRHL2 AR ZFX CD93 STOX2 CSNK1A1 IGSF9 MN1 RBFOX2 | 2.76e-04 | 806 | 96 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 3.05e-04 | 201 | 96 | 6 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.23e-04 | 379 | 96 | 8 | gudmap_developingKidney_e15.5_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.59e-04 | 385 | 96 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500 | 3.72e-04 | 387 | 96 | 8 | gudmap_developingGonad_e16.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.85e-04 | 210 | 96 | 6 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.10e-04 | 138 | 96 | 5 | gudmap_developingGonad_e12.5_epididymis_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | 4.26e-04 | 395 | 96 | 8 | gudmap_developingGonad_P2_epididymis_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_200 | 4.33e-04 | 78 | 96 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_200_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500 | 4.78e-04 | 402 | 96 | 8 | gudmap_developingKidney_e15.5_anlage of loop of Henle_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 4.86e-04 | 403 | 96 | 8 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | CCPG1 RNF168 DOCK11 TRO RNF213 ABCC9 GRHL2 AKAP9 UBP1 LHX5 WDFY3 PDGFC ZNF292 | 5.02e-04 | 989 | 96 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | 5.36e-04 | 409 | 96 | 8 | gudmap_developingGonad_e12.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.67e-04 | 233 | 96 | 6 | gudmap_developingGonad_e12.5_ovary_k5_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#4 | 7.27e-04 | 39 | 96 | 3 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | ARHGAP24 MYCBP2 CPD GRHL2 SPATA1 ZFX AKAP9 CSNK1A1 KIAA1217 RBFOX2 ZNF292 | 7.40e-04 | 774 | 96 | 11 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.51e-04 | 330 | 96 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500 | 8.26e-04 | 161 | 96 | 5 | gudmap_developingGonad_e12.5_ovary_k3_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | 8.73e-04 | 163 | 96 | 5 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.79e-04 | 339 | 96 | 7 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 9.40e-04 | 797 | 96 | 11 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.03e-03 | 564 | 96 | 9 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 1.11e-03 | 172 | 96 | 5 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.54e-08 | 199 | 99 | 8 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.65e-07 | 194 | 99 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.82e-06 | 177 | 99 | 6 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-06 | 177 | 99 | 6 | 14fb8d182775dfd0e49aa7e4e12543a85b3b8bd6 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.82e-06 | 177 | 99 | 6 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.42e-06 | 183 | 99 | 6 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.52e-06 | 184 | 99 | 6 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 3.75e-06 | 186 | 99 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-06 | 187 | 99 | 6 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.99e-06 | 188 | 99 | 6 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.11e-06 | 189 | 99 | 6 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 4.11e-06 | 189 | 99 | 6 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.64e-06 | 193 | 99 | 6 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.64e-06 | 193 | 99 | 6 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.78e-06 | 194 | 99 | 6 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.78e-06 | 194 | 99 | 6 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 5.37e-06 | 198 | 99 | 6 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | Sigmoid-Dendritic_cell-cycling_DCs|Sigmoid / Region, Cell class and subclass | 5.53e-06 | 199 | 99 | 6 | bd6f8c0f79e9a94cc0f8c6105d38851463de821c | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 5.53e-06 | 199 | 99 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-06 | 199 | 99 | 6 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | Sigmoid-(5)_Dendritic_cell-(52)_cycling_DCs|Sigmoid / shred on region, Cell_type, and subtype | 5.53e-06 | 199 | 99 | 6 | 8ee78a39729633bcbb3ab17e1dfaca33f38db569 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 7.57e-06 | 121 | 99 | 5 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 138 | 99 | 5 | a88c3ae56b0af60f6e87cabade4f21e2bbb336f2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-05 | 160 | 99 | 5 | 03b88dc7ad41c6ae443cab7e77ec666340bf432e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.12e-05 | 172 | 99 | 5 | ebeda7ef181cac0109be750a98e7589c615d2724 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.47e-05 | 175 | 99 | 5 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.47e-05 | 175 | 99 | 5 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-05 | 176 | 99 | 5 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-05 | 176 | 99 | 5 | 5e46a09a36b9645b1b1fcb0b64bd0898561af3a9 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-05 | 179 | 99 | 5 | 4166c4e1a8748a79ac6a11fd0b97c5344be2321b | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 5.12e-05 | 180 | 99 | 5 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.12e-05 | 180 | 99 | 5 | 38035cf2c6fbc443ea10ca7e942572715ed572da | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.39e-05 | 182 | 99 | 5 | 21744c9c792e57d5d41b25986f419b2358c7057b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.39e-05 | 182 | 99 | 5 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 5.53e-05 | 183 | 99 | 5 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-05 | 184 | 99 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.68e-05 | 184 | 99 | 5 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.98e-05 | 186 | 99 | 5 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.13e-05 | 187 | 99 | 5 | 8bd635abdee5d5a12a3f7bf74eab4282e8e40741 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.13e-05 | 187 | 99 | 5 | 3cb8cd7f7a4306ff74d1f7f9964014008ec1c6a0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.29e-05 | 188 | 99 | 5 | 2ee64bc73a2251fd9f374be759b442cf4ed0d19e | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.44e-05 | 189 | 99 | 5 | 5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-05 | 189 | 99 | 5 | 38acb307907fde68b992057714448c1561d69ee3 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 6.61e-05 | 190 | 99 | 5 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.61e-05 | 190 | 99 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.77e-05 | 191 | 99 | 5 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 6.77e-05 | 191 | 99 | 5 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.77e-05 | 191 | 99 | 5 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac-Cycling_Myeloid-Mac|GI_small-bowel / Manually curated celltypes from each tissue | 6.77e-05 | 191 | 99 | 5 | c3944332c5226b0113f8aa9ac07837b755606c6c | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.94e-05 | 192 | 99 | 5 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.94e-05 | 192 | 99 | 5 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.94e-05 | 192 | 99 | 5 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.94e-05 | 192 | 99 | 5 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 6.94e-05 | 192 | 99 | 5 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.11e-05 | 193 | 99 | 5 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.11e-05 | 193 | 99 | 5 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.11e-05 | 193 | 99 | 5 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 7.11e-05 | 193 | 99 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.11e-05 | 193 | 99 | 5 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.11e-05 | 193 | 99 | 5 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.11e-05 | 193 | 99 | 5 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 7.29e-05 | 194 | 99 | 5 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.29e-05 | 194 | 99 | 5 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 7.29e-05 | 194 | 99 | 5 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.29e-05 | 194 | 99 | 5 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 7.47e-05 | 195 | 99 | 5 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.47e-05 | 195 | 99 | 5 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 7.65e-05 | 196 | 99 | 5 | 8f0f72ead06abe02b575e443552eacc2151077ef | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 7.84e-05 | 197 | 99 | 5 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.84e-05 | 197 | 99 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | (6)_Macrophage|World / shred on Cell_type and subtype | 7.84e-05 | 197 | 99 | 5 | 010b275d4da4a896175ad7fbaa96d1dc11a0b744 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.03e-05 | 198 | 99 | 5 | c26c909e95225440abdf558b1b858ffc06177000 | |
| ToppCell | Caecum-(6)_Macrophage-(61)_LYVE1_Macrophage|Caecum / shred on region, Cell_type, and subtype | 8.03e-05 | 198 | 99 | 5 | e684c3934c163aef4d284b69435832d2c9614f2a | |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Caecum / Region, Cell class and subclass | 8.03e-05 | 198 | 99 | 5 | a92c0cacb775aca6bbb302bd9e22c081a112a44d | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.22e-05 | 199 | 99 | 5 | b827dd8a249f904a0ff930a6c4d3b00fb7bc6fb1 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.22e-05 | 199 | 99 | 5 | c0dcdda30485bb920d3706dcfb06f11b76b6ea37 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 8.22e-05 | 199 | 99 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.41e-05 | 200 | 99 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.41e-05 | 200 | 99 | 5 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | mLN-Macrophage|mLN / Region, Cell class and subclass | 8.41e-05 | 200 | 99 | 5 | 68d709afd226241e002dae6d6820bccd1cfd87a1 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 8.41e-05 | 200 | 99 | 5 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-05 | 200 | 99 | 5 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 8.41e-05 | 200 | 99 | 5 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | 390C-Endothelial_cells-Endothelial-A_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.41e-05 | 200 | 99 | 5 | 50b8788494b744e0f0ec8c4d67a1c90ae09dca65 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-A_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.41e-05 | 200 | 99 | 5 | f5f24273bee3259a4a3be99ba53b88defa1286c0 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.41e-05 | 200 | 99 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.41e-05 | 200 | 99 | 5 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | mLN-(6)_Macrophage|mLN / shred on region, Cell_type, and subtype | 8.41e-05 | 200 | 99 | 5 | 6dcba82a7d322102bae205543086e84c7655b3e0 | |
| ToppCell | Transverse-Dendritic_cell-cycling_DCs|Transverse / Region, Cell class and subclass | 8.41e-05 | 200 | 99 | 5 | f588d8889f351c797963616a3575fa43efd46b9a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type. | 8.41e-05 | 200 | 99 | 5 | 0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 8.41e-05 | 200 | 99 | 5 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 8.41e-05 | 200 | 99 | 5 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Transverse-(5)_Dendritic_cell-(52)_cycling_DCs|Transverse / shred on region, Cell_type, and subtype | 8.41e-05 | 200 | 99 | 5 | 51e643d48b5e97a0e117b578a6ea7d429c6cdd1e | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-05 | 200 | 99 | 5 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | (52)_cycling_DCs|World / shred on Cell_type and subtype | 8.61e-05 | 201 | 99 | 5 | ad2d25d84345fdd593065516a05c5c2b5429eac0 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.26e-04 | 115 | 99 | 4 | 18b962a49aaf0257ef1b4947c19917fcc6fe5863 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Cortical_neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 3.32e-04 | 148 | 99 | 4 | a1269312903fc27830c1835dabf660c659a711be | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.67e-04 | 152 | 99 | 4 | 6d02b50e9e9ecf820f84a79e46d153a4840a1cfe | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.67e-04 | 152 | 99 | 4 | eb7ff36792c3c54ac88cfe976f84016b70b1a1d7 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.86e-04 | 154 | 99 | 4 | 1f8d127b657976656e4ec292f26d619943533b86 | |
| Disease | Leukemia, Myelocytic, Acute | 2.37e-05 | 173 | 97 | 6 | C0023467 | |
| Disease | Acute Myeloid Leukemia, M1 | 5.94e-05 | 125 | 97 | 5 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 5.94e-05 | 125 | 97 | 5 | C1879321 | |
| Disease | Brugada Syndrome (disorder) | 6.63e-05 | 24 | 97 | 3 | C1142166 | |
| Disease | obsolete_red blood cell distribution width | SP3 ZNF217 SIRPA BMPR2 MFSD14B ATXN7 ZPR1 KIAA1217 PDS5A GKN1 MAPRE2 EP300 RBFOX2 USP47 | 1.29e-04 | 1347 | 97 | 14 | EFO_0005192 |
| Disease | syndromic X-linked intellectual disability Najm type (implicated_via_orthology) | 2.22e-04 | 7 | 97 | 2 | DOID:0060807 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 2.56e-04 | 93 | 97 | 4 | C1535926 | |
| Disease | cortical thickness | A2M MYCBP2 TRIOBP TNRC6B ABCC9 MLLT10 VANGL2 MITF KMT2A IGSF9 PDGFC MAPRE2 | 2.91e-04 | 1113 | 97 | 12 | EFO_0004840 |
| Disease | hearing impairment | 3.13e-04 | 98 | 97 | 4 | C1384666 | |
| Disease | cystatin C measurement | 3.71e-04 | 402 | 97 | 7 | EFO_0004617 | |
| Disease | Prostatic Cancer, Castration-Resistant | 3.79e-04 | 9 | 97 | 2 | C3658266 | |
| Disease | Prostatic Neoplasms, Castration-Resistant | 3.79e-04 | 9 | 97 | 2 | C3658267 | |
| Disease | Abnormality of the face | 3.79e-04 | 9 | 97 | 2 | C4025871 | |
| Disease | brain measurement, neuroimaging measurement | 4.68e-04 | 550 | 97 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | Colorectal Carcinoma | 5.15e-04 | 702 | 97 | 9 | C0009402 | |
| Disease | Shortened QT interval | 5.77e-04 | 11 | 97 | 2 | C0151879 | |
| Disease | Carcinoma, Granular Cell | 5.93e-04 | 116 | 97 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 5.93e-04 | 116 | 97 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 5.93e-04 | 116 | 97 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 5.93e-04 | 116 | 97 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 5.93e-04 | 116 | 97 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 5.93e-04 | 116 | 97 | 4 | C0001418 | |
| Disease | Small cell carcinoma of lung | 7.56e-04 | 54 | 97 | 3 | C0149925 | |
| Disease | neuroimaging measurement | CACNB2 MBP TNRC6B MLLT10 GINS1 VANGL2 RLIM MITF IGSF9 PDGFC MAPRE2 | 7.76e-04 | 1069 | 97 | 11 | EFO_0004346 |
| Disease | leukemia | 7.98e-04 | 55 | 97 | 3 | C0023418 | |
| Disease | serum gamma-glutamyl transferase measurement | SP3 DOCK11 TRIOBP SLCO1B3 KMT2A CGNL1 SIPA1L2 MAPRE2 CNOT4 ZNF292 | 8.56e-04 | 914 | 97 | 10 | EFO_0004532 |
| Disease | Endometrial Neoplasms | 9.32e-04 | 58 | 97 | 3 | C0014170 | |
| Disease | mean corpuscular hemoglobin concentration | NUP50 TNRC6B ZNF217 SIRPA STAT3 BMPR2 UBAP2L ZPR1 KIAA1217 TNFRSF13B MN1 | 1.02e-03 | 1105 | 97 | 11 | EFO_0004528 |
| Disease | schizophrenia (biomarker_via_orthology) | 1.09e-03 | 15 | 97 | 2 | DOID:5419 (biomarker_via_orthology) | |
| Disease | ascending aortic diameter | 1.20e-03 | 140 | 97 | 4 | EFO_0021787 | |
| Disease | transient cerebral ischemia (implicated_via_orthology) | 1.24e-03 | 64 | 97 | 3 | DOID:224 (implicated_via_orthology) | |
| Disease | T-Cell Lymphoma | 1.25e-03 | 16 | 97 | 2 | C0079772 | |
| Disease | melanoma | 1.38e-03 | 248 | 97 | 5 | C0025202 | |
| Disease | JT interval | 1.38e-03 | 248 | 97 | 5 | EFO_0007885 | |
| Disease | heart disease (biomarker_via_orthology) | 1.41e-03 | 17 | 97 | 2 | DOID:114 (biomarker_via_orthology) | |
| Disease | Liver carcinoma | 1.44e-03 | 507 | 97 | 7 | C2239176 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 1.58e-03 | 18 | 97 | 2 | EFO_1000649, HP_0000131 | |
| Disease | Feeding difficulties | 1.58e-03 | 18 | 97 | 2 | C0232466 | |
| Disease | pulse pressure measurement, alcohol drinking | 1.61e-03 | 70 | 97 | 3 | EFO_0004329, EFO_0005763 | |
| Disease | Endometrial Carcinoma | 1.74e-03 | 72 | 97 | 3 | C0476089 | |
| Disease | Brugada syndrome | 1.76e-03 | 19 | 97 | 2 | MONDO_0015263 | |
| Disease | Craniofacial Abnormalities | 1.78e-03 | 156 | 97 | 4 | C0376634 | |
| Disease | prostate cancer (is_marker_for) | 1.78e-03 | 156 | 97 | 4 | DOID:10283 (is_marker_for) | |
| Disease | left atrial function | 2.16e-03 | 21 | 97 | 2 | EFO_0004294 | |
| Disease | idiopathic pulmonary fibrosis (is_marker_for) | 2.59e-03 | 23 | 97 | 2 | DOID:0050156 (is_marker_for) | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 2.59e-03 | 23 | 97 | 2 | C1708353 | |
| Disease | congenital heart disease (is_implicated_in) | 2.82e-03 | 24 | 97 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | low density lipoprotein cholesterol measurement, response to escitalopram, response to citalopram | 2.82e-03 | 24 | 97 | 2 | EFO_0004611, EFO_0006329, EFO_0007871 | |
| Disease | hippocampal volume | 3.03e-03 | 297 | 97 | 5 | EFO_0005035 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GEENSTNNSTGQSRA | 311 | Q9ULK5 | |
| GLDDESNNQQAAATQ | 1711 | Q09472 | |
| SSTQTQNGNENQGEV | 1681 | Q99996 | |
| GGNLATAVTQQVQND | 191 | Q6P093 | |
| AQGQQEQGRGSLQDA | 766 | Q5SNV9 | |
| EAQQQAGESAGAQAA | 1121 | Q5SNV9 | |
| NDSQEGGCNSRQVSN | 561 | Q96BT7 | |
| AVQDTQSRLQNGSSG | 366 | P07510 | |
| SSVATQNNDGTDGQK | 566 | Q9NPY3 | |
| RSNTNGNTDKNTQNG | 151 | Q9NZW4 | |
| NDESDSQSKSGNGNN | 1266 | Q9NZW4 | |
| NETQNGTNNTTGISE | 326 | O60706 | |
| SEVQTDGNSQFASQG | 276 | Q49A88 | |
| QQNAQGGFSSTQDTV | 1241 | P01023 | |
| LASNSQGSQGDQRTD | 491 | Q08289 | |
| NIEQQHGNSGRNSES | 196 | Q9UKX7 | |
| KQQNAQGGFSSTQDT | 1246 | P20742 | |
| GTETGSNINVNSELN | 1161 | Q29RF7 | |
| INSDQATQGNISSDR | 1221 | Q29RF7 | |
| EGGAQTDGQQSQTQS | 96 | O43251 | |
| QNEQRDTQLSSGQLG | 56 | Q6ZSG2 | |
| GEQSQGTQSQGSALQ | 396 | O00255 | |
| SALAGQRQGTQAESN | 11 | Q9NRA1 | |
| RGNSQTFGNSQNIGE | 1136 | O75140 | |
| SVTNGQSNQPSNEGD | 11 | Q9NS87 | |
| DSGNSNGNASINITD | 61 | Q16288 | |
| LQSESSNAAEGNEQR | 61 | Q9NP66 | |
| EESNQGSTASDQQQN | 186 | Q96PQ5 | |
| ENINLTNGSNGRNTE | 171 | Q6P5Q4 | |
| QNGRENNERLSTSNG | 116 | Q6NT76 | |
| TSGLGELNSREQTNQ | 271 | Q5T3I0 | |
| QGSSNGAQDQEASEQ | 481 | Q86W50 | |
| TANNENEEQNSGTKR | 166 | Q9H2C1 | |
| QQQQEAVSEGSSSGR | 196 | P10275 | |
| AQQAASSSGQGQQAQ | 306 | Q8N752 | |
| GGAAAAAARQQQQQQ | 21 | O15265 | |
| GTQTQAGATQTVEQD | 231 | Q9UBG3 | |
| QTQEATNDQNRGTET | 256 | Q9UBG3 | |
| QTQESTNGQNRGTEI | 316 | Q9UBG3 | |
| VTDSRNLTGQSGQNA | 826 | Q9Y5I4 | |
| DSTENPQQGQGRQNA | 6 | Q8N264 | |
| QALQIEQGESSQNGT | 51 | Q9ULG6 | |
| VNDDNNNAGSGQQSV | 26 | Q9NS71 | |
| NNAGSGQQSVSVNNE | 31 | Q9NS71 | |
| SEAQSNLSGGENRVQ | 101 | Q6ISB3 | |
| DQGNTGENTRQSSTR | 1251 | Q5JSL3 | |
| QESAEQGANQGQRGQ | 221 | P49918 | |
| RAAGSAQGNNQACNS | 591 | Q0VF96 | |
| AASDANTGDRGQTNN | 396 | P49841 | |
| NTGDRGQTNNAASAS | 401 | P49841 | |
| EATGQQDFTQTANGQ | 716 | Q13873 | |
| EGDSISVIGRNNSNN | 616 | O75976 | |
| NGENNNDIIQDNNGT | 11 | Q15555 | |
| FGEADANQNNGTSSQ | 46 | P02686 | |
| SVEQGHGNNQDLTRN | 3011 | Q03164 | |
| NSGKEQNDNTSNGTN | 581 | Q96MM7 | |
| VSRNAESDQQGVAQG | 366 | Q5SR56 | |
| QAQGGESQQEAQRLQ | 1576 | Q14980 | |
| VNSRNAGQGERNFNE | 11 | Q10571 | |
| NGGSNPQANRQTSDS | 86 | Q9BRS2 | |
| GQGSVSASVTEGQQN | 306 | P55735 | |
| QSETTAEGGQGQAQE | 751 | Q13671 | |
| QGQGRDRDTQNLQAQ | 161 | Q8TAD8 | |
| SQDIQGRNRDSQNGA | 491 | O14545 | |
| SISDGQLQGGQSNSE | 106 | Q9NYJ8 | |
| SAVNQEGITSNTNNG | 241 | O95486 | |
| AQQAASSSGQGQQAQ | 306 | P48729 | |
| ENAKGESGQSTNREQ | 401 | P04279 | |
| TSVLQNGQSDQSEGQ | 111 | Q9P2F8 | |
| EENGDSVVQNNNTSQ | 1486 | Q5T5P2 | |
| AENNNGATGGQLNTQ | 1026 | Q96ST3 | |
| QGSNTAAENTGSNER | 356 | P78324 | |
| NQSTDSTTGNQPEQG | 1996 | O75592 | |
| AQDEGRSQQPSQGQS | 1326 | Q9H2D6 | |
| QSTQNVTVNARNSEG | 106 | Q13326 | |
| RQTNNGVNEADGTIH | 156 | Q5VX52 | |
| AQSENNQTDQDLGDN | 656 | P55197 | |
| GNGDNSQQISNSDTP | 286 | O95628 | |
| DSAGQRDETGNNSVQ | 886 | Q63HN8 | |
| RDETGNNSVQTVFQG | 891 | Q63HN8 | |
| QGANTVGSIQDVQSE | 621 | Q15468 | |
| NNTEIQSAGRIQDQG | 86 | O75312 | |
| ASNETQTARSHNGGQ | 101 | Q96MU6 | |
| SSRIGDSSQGDNNLQ | 211 | Q05086 | |
| ALNEQGDSRNNSSVE | 526 | Q8IZQ1 | |
| LQQDGQTGSGQRSQT | 1051 | Q14157 | |
| TFNNNLGTGTEANQA | 456 | O75030 | |
| RATESQTPNADQGAQ | 351 | Q12816 | |
| ASQRQQESGGNQEAS | 756 | Q9P2F5 | |
| GNDFDNDRNQGNQVE | 81 | Q7RTT5 | |
| LQTAATAAQQGGQAN | 116 | P40763 | |
| SSDNGGINQESSQIQ | 191 | Q02447 | |
| INVNRNNGSQNSENE | 141 | Q9NVW2 | |
| TNDDRNQTANLTNQG | 301 | Q9NPD5 | |
| SDASQEVGGHQERQQ | 1051 | Q9C0C2 | |
| GSQGAGETSQNAQIN | 1776 | O60281 | |
| QQQQDGDNGDSSKST | 886 | Q96K76 | |
| GRGLQGQAQVDSNSS | 456 | Q9P2J2 | |
| VTQTNGNNTGETENE | 361 | Q8IYW5 | |
| SGTRSGSQQISQDDQ | 81 | Q8IUG5 | |
| QRSGEVENNSDNSGR | 121 | O14836 | |
| HQGDGASQTSGEQIQ | 351 | Q9NZI7 | |
| NNSDGIENRNGTASA | 366 | P17010 | |
| NVGVQGAATRQQQSE | 826 | O75362 | |
| GDSQSQGDQHGESVQ | 571 | Q5QJ38 | |
| EQNQSDVNEAKSGGR | 41 | Q14691 | |
| SNSGNNGNNGKERED | 441 | Q9UPQ9 | |
| GNNSDGIENRNGTAS | 361 | P08048 |